BPI Boston (Bioprocessing International)

Enzene will be attending BPI Boston 2026, and we look forward to connecting with biopharmaceutical organizations seeking a strategic CIDMO™ partner for their next biologic.

Our technical and commercial teams will be on-site to talk through the realities of your program — timelines, capacity constraints, and cost pressures — and how Enzene’s integrated platform can optimize efficiency across the entire development lifecycle, from cell line development to commercial-scale manufacturing.

Meet our team in Boston to:

• Discover how Enzene’s Fully-Connected Continuous Manufacturing™ (FCCM™) platform, EnzeneX®, is driving down mAb production costs industry-wide.
• Discuss tailored, scalable solutions for biologics production — whether you’re scaling up an existing program or starting from platform selection.
• Explore flexible engagement models, including technology transfer into your own facility or full outsourcing to Enzene’s global sites.
• Review real-world case studies on comparability, analytical characterization, and process intensification for complex biologics and mAbs.

Stop by to speak with our technical and commercial leadership or book a dedicated time slot in advance to make the most of your time on the show floor. Also, join our talk at the Innovation & Community Stage: Thursday, September 24th, 11:00 – 11:10 AM.